Teva Pharmaceutical Industries (TEVA) Earnings Date & Reports

Industry: @Pharmaceuticals Generic

A.I. Advisor

published Earnings

TEVA is expected to report earnings to rise 7.61% to 65 cents per share on November 07

Teva Pharmaceutical Industries TEVA Stock Earnings Reports

Q3'24

Est.

$0.66

Q2'24

Beat

by $0.06

Q1'24

Missed

by $0.03

Q4'23

Beat

by $0.23

Q3'23

Est.

$0.60

The last earnings report on July 31 showed earnings per share of 61 cents, beating the estimate of 55 cents. With 6.72M shares outstanding, the current market capitalization sits at 15.06B.

View a ticker or compare two or three

Compare

TEVA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For TEVA
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for TEVA (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a manufacturer of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Pharmaceuticals Generic

Address

124 Dvora HaNeviâ€™a Street

Phone

+972 39148213

Employees

37851

Web

https://www.tevapharm.com